StockVS

NASDAQ · Medical Instruments & Supplies · USD

Zentek Ltd. (ZTEK) Stock Analysis

Zentek Ltd. (ZTEK) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

ZTEK

$0.56

+$0.05 (+9.21%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ZTEK with… →

ZTEK Key Statistics

As of Sep 4, 2026
Trading
Open
$0.48
Previous Close
$0.51
Day's Range
0.48–0.58
52-Week Range
0.37–1.10
Volume
62.46K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.29
Valuation
Market Cap
$62.30M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
575.48
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.07
Financials (FY)
Revenue (FY)
$166.05K−80.97%
Net Income (FY)
−$9.77M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
126.62M
1-Year Return
−36.14%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
212.20K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ZTEK Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−12.19%
2025−31.91%
2024−12.96%
2023−30.32%
2022−60.05%
2021+37.10%
2020+910.71%
2019−6.67%
2018−44.44%
2017−15.63%
2016 (partial year)+28.00%

As of September 4, 2026.

ZTEK Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$166.05K−$9.77M−5882.6%
2024$872.50K−$10.04M−1150.7%
2023$29.82K−$11.70M−39254.1%
2022$72.86K−$14.41M−19784.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$166.05K−$1.67M−$9.93M−$9.77M−5882.6%
2024$872.50K$227.89K−$9.60M−$10.04M−1150.7%
2023$29.82K−$301.26K−$11.98M−$11.70M−39254.1%
2022$72.86K−$780.48K−$14.65M−$14.41M−19784.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

ZTEK Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricZTEKMedical Instruments & Supplies medianvs median
P/S ratio575.483.17181.4x the median
Profit margin0.00%0.85%0.8 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Zentek Ltd. (ZTEK) is capitalised at $62.30M on the latest close. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 10 employees.

Over the past 52 weeks the price has ranged from $0.37 to $1.10. ZTEK last closed at $0.56 on September 4, 2026. That is +$0.05 (+9.21%) against the previous close. The latest close sits 51.89% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $166.05K. That is −80.97% against the prior fiscal year, when revenue was $872.50K. The same year closed with a net loss of $9.77M. Profit margin runs at 0%. That is 0.8 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −0.07.

Across the 4 fiscal years on file, revenue moves from $72.86K in 2022 to $166.05K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 575.48 times revenue. On price-to-sales that is 181.4 times the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 0.29. Daily returns over the trailing 10 years annualize to a volatility of 85.7%. The trailing one-year price return is −36.14%. Across 10 years the annualized return works out at −1.14%.

Growth & Income

No dividend is on file for ZTEK.

2026 is still running; the price is −12.19% year to date. The strongest complete calendar year on file is 2020 at +910.71%; the weakest is 2022 at −60.05%. Of the 9 complete calendar years on file, 2 finished higher.

Peer Comparison

Zentek Ltd. (ZTEK) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Zentek Ltd. ZTEK $62.30M
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Zentek Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Zentek Ltd.

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. It develops graphene-based coatings under the ZenGUARD brand; graphene-enhanced intumescent gel under the ZenFire brand; carbon-based copolymeric icephobic coating under the ZenICE brand, and graphene-enhanced anti-corrosion coating under the ZenArmor brand. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Visit website →